A study says drug approvals way down.
The study presented at a biotechnology industry conference, BIO CEO & Investor Conference, says that the success rate for getting new drugs approved has fallen by about 50%.
Drug companies have been raising more complaints recently about a regulatory environment that has begun to err on the side of safety when reviewing the...
Read More